Feb 03, 2021
Leading Lupus Researchers Recognized for Exceptional Work in the Field
Jan 22, 2021
Lupus Foundation of America Congratulates Aurinia Pharmaceuticals on FDA Approval of Lupkynis(TM) (voclosporin) to Treat Lupus Nephritis
Dec 17, 2020
Lupus Foundation of America Sees Big Win with FDA Approval of Benlysta for Lupus Nephritis
Oct 27, 2020
Lupus Foundation of America Launches Next-Generation, Patient-Powered Data Platform to Accelerate and Advance Lupus Research
Jun 23, 2020
Lupus Foundation of America Survey Finds Over Half of Respondents Experienced Issues Accessing Hydroxychloroquine During Coronavirus Pandemic
Dec 04, 2019
Monumental Treatment Breakthrough for Lupus Kidney Disease
Nov 11, 2019
New data shows benefit of lupus drug
Nov 10, 2019
Leader in Lupus Research and Young Investigator Recognized for Exceptional Contributions and Dedication to Field
Nov 05, 2019
Lupus Foundation of America Announces Development of Next Generation Data Platform to Advance Lupus Research
Sep 25, 2019
Lupus Research Award Supports Early Career Scientists, Funds Study Areas of Critical Need
Sep 10, 2019
Los Angeles Comes Together to Be Powerful and Walk to End Lupus Now
Aug 27, 2019
Fellowship Program Awards Young Scientists, Paves Way for Future Lupus Researchers
Jul 25, 2019
Progentec Diagnostics Awarded SBIR Fast-Track Grant to Develop Immune Mediator-Based Blood Tests for Clinical Disease Activity in Lupus (SLE)
Jul 19, 2019
International Lupus Community Reaches First-Ever Agreement on Barriers to Research, Drug Development, Care and Access
Jul 18, 2019
Dr. Daniel Wallace Appointed to Lupus Therapeutics Board of Directors
Jul 01, 2019
Study Confirms Urgent, Unmet Needs in Childhood-Onset Lupus
Mar 07, 2019
Lupus Foundation of America Launches Global Research News Hub
Jan 31, 2019
Lupus Foundation of America Reinvents its Online Home
Dec 17, 2018
New Report Examines Medicare Part D Access and Affordability Issues
Nov 14, 2018
Advocates and Leaders Honored for their Outstanding Efforts to End Lupus